Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Gross Profit: 2023-2024

Historic Gross Profit for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$4.2 million.

  • Upstream Bio's Gross Profit fell 18.26% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.6 million, marking a year-over-year decrease of 741.40%. This contributed to the annual value of -$4.2 million for FY2024, which is 323.97% down from last year.
  • Per Upstream Bio's latest filing, its Gross Profit stood at -$4.2 million for FY2024, which was down 323.97% from -$993,000 recorded in FY2023.
  • Upstream Bio's Gross Profit's 5-year high stood at -$993,000 during FY2023, with a 5-year trough of -$4.2 million in FY2024.
  • Moreover, its 2-year median value for Gross Profit was -$2.6 million (2023), whereas its average is -$2.6 million.
  • Data for Upstream Bio's Gross Profit shows a maximum YoY crashed of 323.97% (in 2024) over the last 5 years.
  • Upstream Bio's Gross Profit (Yearly) stood at -$993,000 in 2023, then slumped by 323.97% to -$4.2 million in 2024.